Rhode Island § 21-28.11-10.4 § 21-28.11-10.4. Medical marijuana program parity.

Rhode Island Statutes

§ 21-28.11-10.4 — § 21-28.11-10.4. Medical marijuana program parity.

Rhode Island § 21-28.11-10.4

Title 21Food And Drugs

Ch. 21-28.11The Rhode Island Cannabis Act

This text of Rhode Island § 21-28.11-10.4 (§ 21-28.11-10.4. Medical marijuana program parity.) is published on Counsel Stack Legal Research, covering Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

R.I. Gen. Laws § 21-28.11-10.4 (2026).

Text

§ 21-28.11-10.4. Medical marijuana program parity.
No later than April 1, 2024, the commission shall, in collaboration with the department
            of health and the office of management and budget, conduct and deliver to the governor,
            the speaker of the house of representatives, and the president of the senate a study
            relating to the impact of the implementation of adult use cannabis in Rhode Island
            on the existing medical marijuana program (MMP) established pursuant to chapter 28.6
            of this title. This study shall examine and make recommendations relating to, without
            limitation, the following:
         
(1) The extent 

Free access — add to your briefcase to read the full text and ask questions with AI

§ 21-28.11-10.4. Medical marijuana program parity.

No later than April 1, 2024, the commission shall, in collaboration with the department of health and the office of management and budget, conduct and deliver to the governor, the speaker of the house of representatives, and the president of the senate a study relating to the impact of the implementation of adult use cannabis in Rhode Island on the existing medical marijuana program (MMP) established pursuant to chapter 28.6 of this title. This study shall examine and make recommendations relating to, without limitation, the following:

(1) The extent to which the introduction of adult use cannabis has diminished or eliminated the availability of certain medical marijuana products or product types;

(2) The extent to which patient cardholders in Rhode Island have experienced new or greater obstacles to obtaining medical marijuana, including on the basis of price, quantity, product type, or geographic location;

(3) The extent to which the number of caregiver registrations and/or the number of plant tag certificates issued by the commission increases or decreases; and

(4) The extent to which the introduction of the new adult use cannabis tax and license fee structure requires a realignment of the existing medical marijuana tax and license fee structure.